9.69 USD
-0.15 (-1.52%)
Taking everything into account, MTEX scores 2 out of 10 in our fundamental rating. MTEX was compared to 35 industry peers in the Personal Care Products industry. MTEX has a bad profitability rating. Also its financial health evaluation is rather negative. MTEX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
MTEX had negative earnings in the past year.
MTEX had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MTEX reported negative net income in multiple years.
In multiple years MTEX reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of MTEX (-11.93%) is worse than 77.14% of its industry peers.
With a Return On Equity value of -65.56%, MTEX is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.93% | ||
| ROE | -65.56% | ||
| ROIC | N/A |
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of MTEX has remained more or less at the same level.
MTEX's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 75.79%, MTEX belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Gross Margin of MTEX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for MTEX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.79% |
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
2. Health
2.1 Basic Checks
MTEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MTEX has been increased compared to 1 year ago.
The number of shares outstanding for MTEX has been reduced compared to 5 years ago.
Compared to 1 year ago, MTEX has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.69 indicates that MTEX is not in any danger for bankruptcy at the moment.
The Altman-Z score of MTEX (3.69) is better than 71.43% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that MTEX is somewhat dependend on debt financing.
MTEX has a Debt to Equity ratio (0.58) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.69 |
ROIC/WACCN/A
WACC9.07%
2.3 Liquidity
A Current Ratio of 1.11 indicates that MTEX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.11, MTEX is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
MTEX has a Quick Ratio of 1.11. This is a bad value and indicates that MTEX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.49, MTEX is doing worse than 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
MTEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -220.34%.
The Earnings Per Share has been decreasing by -0.73% on average over the past years.
Looking at the last year, MTEX shows a decrease in Revenue. The Revenue has decreased by -7.72% in the last year.
Measured over the past years, MTEX shows a decrease in Revenue. The Revenue has been decreasing by -5.66% on average per year.
EPS 1Y (TTM)-220.34%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%-587.36%
Revenue 1Y (TTM)-7.72%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-7.43%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MTEX. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MTEX.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 21.57 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 8.83%, MTEX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.49, MTEX pays a better dividend. On top of this MTEX pays more dividend than 94.29% of the companies listed in the same industry.
MTEX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.83% |
5.2 History
MTEX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:MTEX (11/25/2025, 4:30:01 PM)
9.69
-0.15 (-1.52%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners18.95%
Inst Owner Change1.12%
Ins Owners44.9%
Ins Owner Change0%
Market Cap18.41M
Revenue(TTM)112.97M
Net Income(TTM)-3.91M
Analysts0
Price TargetN/A
Short Float %2.18%
Short Ratio0.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.83% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.16 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.09 | ||
| P/tB | 3.09 | ||
| EV/EBITDA | 21.57 |
EPS(TTM)-2.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.07
OCFYN/A
SpS59.46
BVpS3.14
TBVpS3.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.93% | ||
| ROE | -65.56% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.79% | ||
| FCFM | N/A |
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
F-Score3
Asset Turnover3.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.39 | ||
| Cap/Depr | 60.38% | ||
| Cap/Sales | 0.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 3.69 |
F-Score3
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)43.45%
Cap/Depr(5y)43.17%
Cap/Sales(3y)0.53%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.34%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%-587.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.72%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-7.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.57%
EBIT growth 3Y-45.85%
EBIT growth 5Y-25.91%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y55.05%
FCF growth 3Y-42.1%
FCF growth 5Y-11.9%
OCF growth 1Y62.38%
OCF growth 3Y-40.57%
OCF growth 5Y-14.4%
MANNATECH INC / MTEX FAQ
Can you provide the ChartMill fundamental rating for MANNATECH INC?
ChartMill assigns a fundamental rating of 2 / 10 to MTEX.
Can you provide the valuation status for MANNATECH INC?
ChartMill assigns a valuation rating of 0 / 10 to MANNATECH INC (MTEX). This can be considered as Overvalued.
What is the profitability of MTEX stock?
MANNATECH INC (MTEX) has a profitability rating of 2 / 10.
How financially healthy is MANNATECH INC?
The financial health rating of MANNATECH INC (MTEX) is 3 / 10.
How sustainable is the dividend of MANNATECH INC (MTEX) stock?
The dividend rating of MANNATECH INC (MTEX) is 5 / 10 and the dividend payout ratio is 0%.